1412 INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS by Gane, E.J, Pockros, P, Zeuzem, S, Marcellin, P, Shikhman, A, Bernaards, C, Yetzer, E.S, Shulman, N, Tong, X, Najera, I, Bertasso, A, Hammond, J, Stancic, S

Get full text

1177 RAPID AND SUSTAINED ACHIEVEMENT OF UNDETECTABLE HCV RNA DURING TREATMENT WITH RITONAVIR-BOOSTED DANOPREVIR/PEG-IFNa-2A/RBV IN HCV GENOTYPE 1 OR 4 PATIENTS: DAUPHINE WEEK 12 IN... by Everson, G, Cooper, C, Hezode, C, Shiffman, M.L, Yoshida, E, Beltran-Jaramillo, T, Ferenci, P, Zeuzem, S, Brunda, M, Shulman, N, Navarro, M, Voulgari, A, Najera, I, Le Pogam, S, Yetzer, E.S

Get full text

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS ST... by Marcellin, P, Cooper, C, Balart, L.A, Larrey, D.G, Box, T.D, Yoshida, E, Lawitz, E, Buggisch, P, Ferenci, P, Weltman, M, Labriola-Tompkins, E, Le Pogam, S, Nájera, I, Thomas, D.N, Hooper, G, Shulman, N, Zhang, Y, Navarro, M.T, Lim, C.Y, Brunda, M, Yetzer, E.S, Terrault, N

Get full text